Asia- Pacific Minimally Invasive Devices Market Forecast 2017-2025

Asia- Pacific Minimally Invasive Devices Market Forecast 2017-2025

  • June 2017 •
  • 81 pages •
  • Report ID: 4965004
KEY FINDINGS
The Asia-Pacific minimally invasive devices market is expected to grow at a CAGR of 8.4% during the forecast period of 2017-2025. The market is anticipated to generate a revenue of $2268.94 million by 2025. Growing medical tourism toward Asia-Pacific countries due to the low cost of surgery is believed to aid the market remuneration in countries such as China, India, Singapore, and Malaysia. The market in APAC is expected to expand at a significant pace during the forecast period, with Japan being a major contributor.


MARKET INSIGHTS
The Asia-Pacific market is segmented on the basis of application, equipment type, and end user. The various advances in technology, rising prevalence of spinal disorders, increase in the number of physician-owned ASCS, and the growing popularity of minimally invasive procedures are the major drivers for the market growth in this region. However, the market is facing some tough restraints due to the fact that there is a scarcity of skilled surgeons in the region and the cost of treatment is comparatively high.



COMPETITIVE INSIGHTS
The major companies in the Asia-Pacific market include Hitachi High- Technologies Corporation, Integrated Endoscopy Inc., Intuitive Medtronic Inc., Hologic, Inc., Olympus Optical Co. Ltd., Surgical, Inc, Philips Healthcare, Stryker Corp, Toshiba Medical Systems, Smith & Nephew Plc, Zimmer-Biomet Holdings, Abbot Laboratories, C. R. Bard, Inc, Conmed Corp, Boston Scientific, Ethicon Inc., Getinge AB, Hill-Rom Holdings, and Cooper Surgical Inc.
Country=APAC Industry=HealthServices ParentIndustry=LifeSciences Date=201706 Topic=Forecast Publisher=InkwoodResearch Price=2000